Sign inGet started

Mendelsohn Michael

Insider CIK 1591109 · RGDO Director · CYCN Director · FHTX Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
FHTX Foghorn Therapeutics Inc. A Award deriv2026-06-242026-06-2528,000$4.08 $114.2K28,000SEC↗
FHTX Foghorn Therapeutics Inc. A Award deriv2025-06-172025-06-1725,000$4.79 $119.8K25,000SEC↗
FHTX Foghorn Therapeutics Inc. A Award deriv2024-06-262024-06-2816,000$5.52 $88.3K16,000SEC↗
FHTX Foghorn Therapeutics Inc. A Award deriv2023-06-212023-06-2216,000— $016,000SEC↗
FHTX Foghorn Therapeutics Inc. A Award deriv2022-06-212022-06-2216,000— $016,000SEC↗
CYCN Cyclerion Therapeutics, In A Award deriv2022-06-142022-06-1620,000— $020,000SEC↗
FHTX Foghorn Therapeutics Inc. A Award deriv2021-07-132021-07-1412,530— $012,530SEC↗
CYCN Cyclerion Therapeutics, In A Award deriv2021-06-242021-06-2810,000— $010,000SEC↗
CYCN Cyclerion Therapeutics, In A Award deriv2020-06-162020-06-1810,000— $010,000SEC↗
CYCN Cyclerion Therapeutics, In A Award deriv2019-06-012019-06-0410,000— $010,000SEC↗
CYCN Cyclerion Therapeutics, In A Award2019-04-012019-04-032,421— $02,421SEC↗
RGDO Regado Biosciences Inc A Award deriv2015-01-012015-01-05159,261— $0159,261SEC↗
RGDO Regado Biosciences Inc A Award deriv2014-01-012014-01-034,820— $04,820SEC↗